Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial anionic phospholipid membranes are essential structural components that define the boundary of the bacterial cell and maintain the electrochemical gradient necessary for energy production (Strahl & Errington, 2017). These membranes are characterized by a high proportion of negatively charged phospholipids, such as phosphatidylglycerol and cardiolipin, which differ significantly from the predominantly zwitterionic phospholipids found in mammalian cell membranes (Zhang & Rock, 2008). This biochemical distinction allows for the development of selective antimicrobial agents that target the bacterial surface through electrostatic interactions. Drugs like daptomycin and polymyxins exploit this negative charge to bind, insert, and disrupt the membrane integrity, leading to rapid depolarization and cell death (Malanovic & Lohner, 2016). Beyond serving as a physical barrier, these membranes host critical proteins involved in cell wall synthesis, protein secretion, and signal transduction, making them a multifaceted target for therapeutic intervention in various bacterial infections (Epand et al., 2016). The integrity of this membrane is vital for bacterial survival regardless of metabolic state, making it an effective target for both actively growing and persistent infections (Hurdle et al., 2011).
Antibiotics targeting these membranes typically utilize electrostatic attraction to bind to anionic lipid headgroups, followed by hydrophobic insertion into the bilayer. This process leads to membrane thinning, pore formation, or depolarization, which causes the leakage of vital intracellular ions and metabolites, effectively neutralizing the bacterial cell's ability to maintain homeostasis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial anionic phospholipid membrane.